Vanguard Group Inc Maravai Lifesciences Holdings, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,658,941 shares of MRVI stock, worth $26.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,658,941
Previous 11,821,424
1.37%
Holding current value
$26.2 Million
Previous $64.4 Million
60.01%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MRVI
# of Institutions
208Shares Held
129MCall Options Held
267KPut Options Held
648K-
Gtcr LLC20.2MShares$45.3 Million4.99% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$28.2 Million4.53% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$21.9 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$18.8 Million1.13% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A66.11MShares$13.8 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $296M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...